投资工具 / 美股
West Pharmaceutical Services · WST
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-10-29 | $874.5M | +8.7% | −5.1pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-07-23 | $872.3M | +13.8% | −7.2pp | 3M |
| 2026Q1 | 2026-03-31 | 2026-04-23 | $844.9M | +21.0% | +13.5pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-10-29 | $805M | +7.5% | −0.2pp | FY-9M |
| 2025Q3 | 2025-09-30 | 2026-10-29 | $804.6M | +7.7% | −1.4pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-07-23 | $766.5M | +9.2% | +8.8pp | 3M |
| 2025Q1 | 2025-03-31 | 2026-04-23 | $698M | +0.4% | −1.9pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-17 | $748.8M | +2.3% | +2.4pp | FY-9M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $347.4M | $527.1M | 39.7% | +199bp | +315bp | +114bp |
| 2026Q2 | 2026-06-30 | $329.2M | $543.1M | 37.7% | +266bp | +201bp | +15bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $43.7M | −7.6% | 无数据 | 无数据 | $872.5M | +8.3% | 无数据 |
| 2026Q2 | 2026-06-30 | $45.7M | −1.1% |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $654.5M | −5.7% | $201.1M | −36.1% | $453.4M | 5.9% | 6.3% | 0.8% |
| 2026Q2 | 2026-06-30 | $662.2M |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $464.7M | +6.1% | +8.7% | −2.6pp | 80.4 | +2.1 |
| 2026Q2 | 2026-06-30 | $447.4M | +6.2% | +13.8% | −7.6pp | 75.2 |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 2026-09-15 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,524 | $365.00 | $921.26K | ✓ |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
暂无警报
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-31 | $296.4M | $548.5M | 35.1% | −267bp | +186bp | +64bp |
| 2025Q4 | 2025-12-31 | $303.9M | $501.1M | 37.8% | +117bp | +121bp | +8bp |
| 2025Q3 | 2025-09-30 | $294.3M | $510.3M | 36.6% | +84bp | +114bp | −184bp |
| 2025Q2 | 2025-06-30 | $273.9M | $492.6M | 35.7% | +251bp | +297bp | +285bp |
| 2025Q1 | 2025-03-31 | $231.9M | $466.1M | 33.2% | −331bp | +12bp | +159bp |
| 2024Q4 | 2024-12-31 | $273.6M | $475.2M | 36.5% | +110bp | −147bp | +167bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 无数据 |
| $855.8M |
| +11.9% |
| 无数据 |
| 2026Q1 | 2026-03-31 | $62.2M | +30.1% | 无数据 | 无数据 | $853.4M | +23.2% | 无数据 |
| 2025Q4 | 2025-12-31 | $53.7M | +0.9% | 无数据 | 无数据 | $811.4M | +8.4% | 无数据 |
| 2025Q3 | 2025-09-30 | $47.3M | −12.1% | 无数据 | 无数据 | $805.7M | +7.6% | 无数据 |
| 2025Q2 | 2025-06-30 | $46.2M | −11.5% | 无数据 | 无数据 | $764.9M | +9.8% | 无数据 |
| 2025Q1 | 2025-03-31 | $47.8M | −17.4% | 无数据 | 无数据 | $692.6M | −1.0% | 无数据 |
| 2024Q4 | 2024-12-31 | $53.2M | −1.3% | 无数据 | 无数据 | $748.2M | +1.7% | 无数据 |
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: 总额 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −2.1% |
| $225.3M |
| −32.3% |
| $436.9M |
| 6.8% |
| 7.5% |
| 1.0% |
| 2026Q1 | 2026-03-31 | $715.3M | +7.6% | $257.3M | −28.1% | $458M | 8.0% | 6.4% | 0.9% |
| 2025Q4 | 2025-12-31 | $754.8M | +15.5% | $285.9M | −24.2% | $468.9M | 9.3% | 5.1% | 0.8% |
| 2025Q3 | 2025-09-30 | $693.8M | −1.2% | $314.7M | −17.4% | $379.1M | 10.4% | 5.6% | 0.7% |
| 2025Q2 | 2025-06-30 | $676.7M | −10.1% | $332.7M | −15.8% | $344M | 11.2% | 5.3% | 0.6% |
| 2025Q1 | 2025-03-31 | $664.6M | −12.2% | $357.7M | −3.5% | $306.9M | 12.4% | 4.9% | 0.5% |
| 2024Q4 | 2024-12-31 | $653.4M | −15.9% | $377M | +4.1% | $276.4M | 13.0% | 6.8% | 0.6% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −2.8 |
| 2026Q1 | 2026-03-31 | $452.6M | +16.4% | +21.0% | −4.6pp | 75.3 | −0.8 |
| 2025Q4 | 2025-12-31 | $443.9M | +17.7% | +7.5% | +10.2pp | 80.8 | +8.4 |
| 2025Q3 | 2025-09-30 | $438M | +9.2% | +7.7% | +1.4pp | 78.3 | +2.4 |
| 2025Q2 | 2025-06-30 | $421.1M | +0.5% | +9.2% | −8.7pp | 78.0 | −3.0 |
| 2025Q1 | 2025-03-31 | $388.7M | −9.6% | +0.4% | −10.0pp | 76.1 | −8.2 |
| 2024Q4 | 2024-12-31 | $377M | −13.3% | +2.3% | −15.6pp | 72.4 | −15.0 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026-09-14 |
| 2026-09-15 |
| Favorite Annette F |
| Sr. VP & Chief HR Officer |
| S |
| 2,500 |
| $355.00 |
| $887.5K |
| ✓ |
| 2026-09-11 | 2026-09-15 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,500 | $345.00 | $862.5K | ✓ |
| 2026-09-08 | 2026-09-10 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,817 | $340.81 | $960.06K |
| 2026-09-08 | 2026-09-10 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,500 | $340.81 | $852.03K |
| 2026-09-08 | 2026-09-10 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,818 | $340.81 | $960.4K |
| 2026-04-27 | 2026-04-29 | Favorite Annette F | Sr. VP & Chief HR Officer | S | 2,817 | $305.20 | $859.75K |
| 2026-04-27 | 2026-04-29 | Winters Chad | VP, Chief Accounting Officer | S | 896 | $300.67 | $269.4K |
| 2024-10-29 | 2024-10-31 | Witherspoon Charles | VP & Treasurer | S | 478 | $310.40 | $148.37K |
| 2024-10-29 | 2024-10-31 | Witherspoon Charles | VP & Treasurer | S | 225 | $310.40 | $69.84K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk